Hereditary Cancer

StoreGene offers the most comprehensive hereditary cancer package offering clinicians a powerful tool to provide personalised treatment for their patients. Hereditary cancer syndromes account for approximately 5-10% of all cancer. This test evaluates 82 genes for variation that indicate a significantly increased risk of developing certain types of cancers. In most cases, cancer mortality can be significantly reduced in high-risk individuals by regular surveillance and preventive strategies. This package gives patients the knowledge and support they need to take charge of their health.

This package contains 2 tests in 1, including the most up-to-date Hereditary cancer panel (82 Genes), cancer medication response to determine your metabolising status for a number of cancer medications including Capecitabine, Fluorouracil, Mecaptopurine, Rasburicase and Tamoxifen.

Clinicians are equipped with actionable information to create tailored treatment plans. These plans are based on a patient’s genetic profile, enabling more precise medication selection, lifestyle recommendations, and monitoring strategies

Requirements: Blood Sample or Transfer of Whole Genome Data

Sequencing Time: 30 days

Analysis Time: 24 hours